Profile
Dr Thinesh graduated with a Bachelor of Medicine and Bachelor of Surgery (MbChB) from the University of Glasgow, UK. He then completed post graduate exams in Internal Medicine (MRCP UK) prior to returning to Singapore. He subsequently obtained specialist accreditation in the field of Gastroenterology & Hepatology and was subsequently awarded a 1-year SingHealth HMDP fellowship at the Liver Unit, Queen Elizabeth Hospital, Birmingham, UK where he underwent further sub-speciality training in hepatology with a focus in liver transplant medicine.
He is currently the Director for Clinical Services for the SingHealth Duke-NUS Liver Transplant Centre and a senior consultant in the Department of Gastroenterology and Hepatology, SGH. In addition to his clinical and teaching responsibilities, he serves as Treasurer for the National Foundation for Digestive Diseases and is a member of the executive committee for the Society of Transplantation (Singapore).
His areas of interest include liver transplantation and liver failure, viral hepatitis, metabolic & drug induced liver injury.
Education
- Certificate of Specialist Accreditation (Gastroenterology), Specialist Accreditation Board, Ministry of Health Singapore
- MRCP (UK)
- MBChB (University of Glasgow)
View More +
Professional Appointments and Committee Memberships
- Adjunct Assistant Professor, Duke-NUS Medical School
- Senior Clinical Lecturer, NUS Yong Yoo Lin School of Medicine
- Director for Clinical Services, SingHealth Duke-NUS Liver Transplant Centre
- Liver Transplant Subcommittee Member, Ministry of Health, Singapore
- Eldershield Review Committee Member, Ministry of Health, Singapore 2016 – 2018
- Society of Transplantation (Singapore) Executive Committee Member
- National Foundation for Digestive Diseases, Treasurer
View More +
Awards
- SingHealth Health Manpower Development Plan Award 2014 for Acute Liver Injury
- SingHealth Best Registrar Award 2013
- SingHealth Service Quality Gold Award April 2011 – March 2012
- SingHealth Service Quality Award May 2012
- SingHealth Service Quality Award June 2011
View More +
Publications
- Hepatitis B / T-cell immunotherapy for post liver transplant hepatocellular carcinoma (Phase 1 clinical study) in collaboration with Duke-NUS medical school, ongoing from 2017.
- Kwan, C, Kumar R, Lim R, Krishnamoorthy TL. Understanding the Hepatitis B core positive donor. Accepted for publication SMJ 2017.
- Krishnamoorthy TL, Miezynska-Kurtycz J, Hodson J, Gunson BK, Neuberger J, Milkiewicz P, Oo YH. Long-term corticosteroid use after liver transplantation for autoimmune hepatitis is safe and associated with a lower incidence of recurrent disease. Liver Transpl 2016 Jan; 22(1):34-31.
- Krishnamoorthy TL, Mutimer D. Hepatitis B: encouraging the use of interferon. Curr Opin Infect Dis. 2015 Dec; 28(6):557-62.
- Kumar R, Krishnamoorthy TL, Tan HK, Lui HF, Chow WC. Change in model for end-stage liver disease score at two weeks, as an indicator of mortality or liver transplantation at 60 days in acute-on-chronic liver failure. Gastroenterol Rep (Oxf). 2015 May; 3(2):122-7s
View More +
